PRODUCTS SOLD ON PEPTIDESLABIRELAND.COM ARE FOR RESEARCH PURPOSES ONLY AND ARE NOT FOR HUMAN OR VETERINARY USE.
PRODUCTS SOLD ON PEPTIDESLABIRELAND.COM ARE FOR RESEARCH PURPOSES ONLY AND ARE NOT FOR HUMAN OR VETERINARY USE.
BPC-157 — formally Body Protection Compound-157 — is a synthetic pentadecapeptide consisting of 15 amino acids, derived from a partial sequence of human gastric juice protein. Since the early 1990s it has been one of the most studied peptides in European preclinical research. For Irish research teams looking to source BPC-157 in Ireland, this page provides a complete reference: its molecular profile, the published research landscape, quality standards, and how to obtain it through a verified Irish supplier.
This is a research reference only. BPC-157 is not a licensed medicine in Ireland or the EU. It is not approved for human or veterinary administration and is supplied exclusively for in-vitro and preclinical laboratory research purposes.
BPC-157 has the amino acid sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val. Its molecular formula is C₆₂H₉₈N₁₆O₂₂, with a molecular weight of approximately 1,419.5 Da. It is typically supplied in lyophilised (freeze-dried) form and reconstituted with bacteriostatic water prior to use in research protocols. The compound is notable for its stability in gastric juice in vivo — unusual for peptides of its class — which has made it a sustained focus of GI and systemic repair pathway research.
The volume of published preclinical literature on BPC-157 is substantial. The majority of foundational studies were conducted at the University of Zagreb, led by Professor Predrag Sikiric, with subsequent studies published across European and international journals.
A significant body of BPC-157 research has focused on tissue repair models. Studies in rodent models have examined its influence on muscle, tendon, ligament, and bone tissue healing, with researchers noting effects on nitric oxide signalling, VEGF (vascular endothelial growth factor) pathways, and FAK (focal adhesion kinase) activation. These mechanisms are of active interest to researchers studying wound healing and regenerative biology.
Given its origin as a gastric juice fragment, BPC-157 has been extensively studied in GI tract models — NSAID-induced gastric lesion models, inflammatory bowel disease models, and short bowel syndrome models in rodents. Multiple preclinical studies have documented its counteraction of ethanol-, aspirin-, and stress-induced GI lesions.
BPC-157 has been studied for its effects on angiogenesis — the formation of new blood vessels. Researchers have documented upregulation of VEGFR2 expression in ischaemia and wound healing models, making it of interest in vascular biology research programmes.
More recently, BPC-157 has appeared in research examining neuroprotective mechanisms, dopaminergic signalling, and behavioural models of anxiety and depression in rodents. These studies remain early-stage and primarily preclinical.
When sourcing BPC-157 in Ireland, purity verification is the single most critical factor. The preclinical research community requires a minimum of 98% purity confirmed by HPLC for results to be reproducible and credible. Compounds of unknown or unverified purity introduce confounding variables that undermine any research protocol.
Peptides Lab Ireland supplies BPC-157 with the following documentation as standard on every batch:
All BPC-157 is dispatched from within Ireland with cold-chain packaging and tracked delivery. No international customs delays, no extended transit times that compromise stability.
BPC-157 in lyophilised form should be stored at -20°C for long-term stability. Short-term storage at 4°C is acceptable if it will be used within a short research window. After reconstitution with bacteriostatic water, keep the solution refrigerated. For multi-use protocols, aliquot reconstituted solution into single-use volumes before freezing — repeated freeze-thaw cycles degrade the compound over time.
BPC-157 is not a controlled substance under Irish or EU law and is not classified as a licensed medicine. It is legal to purchase and possess for in-vitro laboratory research purposes. It cannot legally be sold for human administration or used in clinical treatment. See our full guide: Are Peptides Legal in Ireland?
Research-grade BPC-157 should show ≥98% purity on HPLC analysis. All batches supplied by Peptides Lab Ireland are tested to this standard with documentation provided at the point of purchase.
In lyophilised form with a batch-specific CoA, HPLC certificate, and MS identity confirmation. Cold-chain packaging is standard on all Irish deliveries.
Standard delivery to Irish addresses is 1–3 working days from dispatch. Tracked on every order.
BPC-157 is supplied by Peptides Lab Ireland for in-vitro laboratory and scientific research purposes only. It is not a licensed medicine. It has not been approved for human or veterinary use by the HPRA or any EU regulatory authority. It must not be administered to humans or animals. For medical concerns, consult a qualified healthcare professional.
Receive News
